"German pharmaceutical giant Bayer AG has challenged a ground-breaking Indian ruling that allowed a local firm to produce a vastly cheaper copy of its patented drug for kidney and liver cancer. (AFP Photo/Axel Schmidt)" title
View the Original article
No comments:
Post a Comment